Physician profile
Shawnee Thomas
NPI 1952814204
$3,507.94
in general payments reported to CMS, 2019-2025
21 companies · $753 in 2025
The $753 reported for 2025 was more than what 82% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $527 · 2022: $567 · 2023: $973 · 2024: $688 · 2025: $753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,414.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,169.04 | 2021-2025 | |
| Novo Nordisk INC | $527.71 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $489.32 | 2021-2025 | Lokelma, Airsupra, Farxiga |
| Lilly USA, LLC | $249.41 | 2021-2025 | Zepbound, Jardiance, Mounjaro |
| Pfizer INC. | $216.33 | 2021-2023 | |
| Glaxosmithkline, LLC. | $197.90 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.43 | 2021-2022 | |
| Astellas Pharma US INC | $83.79 | 2024-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $70.41 | 2022-2025 | |
| Exact Sciences Corporation | $70.30 | 2023-2025 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $55.90 | 2021 | |
| Merck Sharp & Dohme LLC | $53.01 | 2021-2023 | Belsomra, Steglatro |
| Abbott Laboratories | $40.17 | 2021-2022 | |
| Alkermes, INC. | $38.53 | 2025 | Aristada, Lybalvi, Vivitrol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.18 | 2024-2025 | Xifaxan |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $24.24 | 2023 | Aptima |
| Amgen INC. | $23.10 | 2022 | |
| Exeltis, USA INC. | $21.35 | 2021 | |
| Tactile Systems Technology INC | $16.21 | 2025 | Flexitouch Plus, Nimbl |
| Inspire Medical Systems, INC. | $14.21 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $13.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawnee Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.